MDS-352 Myelodysplastic syndromes with concomitant SF3B1 mutation and deletion of the long arm of chromosome 5
Zaker Schwabkey(King Abdullah University Hospital), Guillermo Garcia‐Manero(The University of Texas MD Anderson Cancer Center), Maximilian Stahl(Harvard University), Pierre Fenaux(Saint Louis University Hospital), Luis E. Aguirre(Harvard University), David A. Sallman(Moffitt Cancer Center), Angela Consagra(Azienda Ospedaliero-Universitaria Careggi), Koji Sasaki(The University of Texas MD Anderson Cancer Center), Anne Sophie Kubasch(Leukemia and Lymphoma Society), Amy E. DeZern(Johns Hopkins University), Somedeb Ball(Vanderbilt University), Eric Padron(Moffitt Cancer Center), Zhuoer Xie(Mayo Clinic), Michael R. Savona(Vanderbilt University), Matteo Della Porta(University of Milan), Mikkael A. Sekeres(University of Miami), Namrata S. Chandhok(Sylvester Comprehensive Cancer Center), Najla Al Ali(Moffitt Cancer Center), María Díez‐Campelo(Complejo Hospitalario de Salamanca), Lin‐Pierre Zhao, Emily F. Mason(Vanderbilt University Medical Center), Uwe Platzbecker(National Center for Tumor Diseases), Akhil Jain(The University of Texas MD Anderson Cancer Center), Luca Lanino(Humanitas University), Yazan F. Madanat(The University of Texas Southwestern Medical Center), Valeria Santini(Azienda Ospedaliero-Universitaria Careggi), Rami S. Komrokji(Moffitt Cancer Center), Mónica Del Rey González(Universidad de Salamanca), Kensuke Takaoka(The University of Texas MD Anderson Cancer Center)
Cited by 0
Related Papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
|Blood|2022|3.1k
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.8k
Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia
|New England Journal of Medicine|2013|1.6k